About Proof Diagnostics

What does Proof Diagnostics do?

Proof Diagnostics is a provider of life sciences tools, diagnostics, and computational discovery solutions, offering a smart, portable CRISPR-based and other technology diagnostic system for rapid, low-cost, sensitive detection of infectious diseases (e.g., SARS-CoV-2, Flu A/B, RSV) and other diseases, OMEGA libraries of RNA-programmable non-Cas enzymes for genome engineering, and gene therapy services leveraging these tools.

Who are Proof Diagnostics's competitors?

Proof Diagnostics's competitors and similar companies include Claritas Pharmaceuticals, Novan, BioAegis Therapeutics, LigoCyte Pharmaceuticals, and Elion Therapeutics.

Where is Proof Diagnostics headquartered?

Proof Diagnostics is headquartered in United States.

How many employees does Proof Diagnostics have?

Proof Diagnostics has 1,000 employees 🔒.

When was Proof Diagnostics founded?

Proof Diagnostics was founded in 2010 🔒.

What sector and industry vertical is Proof Diagnostics in?

Proof Diagnostics is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Proof Diagnostics

Who are the top strategic acquirers in Proof Diagnostics's sector and industry

Top strategic M&A buyers and acquirers in Proof Diagnostics's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Proof Diagnostics?

Top strategic M&A buyers groups and sectors for Proof Diagnostics include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Proof Diagnostics's sector and industry vertical

Which are the top PE firms investing in Proof Diagnostics's sector and industry vertical?

Top PE firms investing in Proof Diagnostics's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Proof Diagnostics's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Proof Diagnostics's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Proof Diagnostics's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Proof Diagnostics include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Proof Diagnostics's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Proof Diagnostics?

The key public trading comparables and valuation benchmarks for Proof Diagnostics include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Proof Diagnostics for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Proof Diagnostics with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Proof Diagnostics's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Proof Diagnostics with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Proof Diagnostics's' sector and industry vertical?

Access recent funding rounds and capital raises in Proof Diagnostics's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.